Local social vulnerability as a predictor for cancer-related mortality among US counties

2024-9-14

Early follow-up of outpatients with oral anticancer therapy in the ONCORAL multidisciplinary community-hospital program

2024-9-14

Safety of a short-term infusion of fosnetupitant in patients with gastrointestinal and breast cancer: a prospective study

2024-9-11

Characterization of driver mutations identifies gene signatures predictive of prognosis and treatment sensitivity in multiple myeloma

2024-9-9

Pre-existing cardiovascular disease is associated with an increased risk of cardiovascular events during Bruton tyrosine kinase inhibitor therapy

2024-9-8

Association between sidedness and survival among chemotherapy refractory metastatic colorectal cancer patients treated with trifluridine/tipiracil or regorafenib

2024-9-7

Radiotherapy with targeted and immunotherapy improved overall survival and progression-free survival for hepatocellular carcinoma with portal vein tumor thrombosis

2024-9-4

In reply: espying sarcopenia in gastric cancer: squaring the circle.

2024-9-3

Nab-paclitaxel plus S-1 followed by gemcitabine-oxaliplatin as first-line alternating sequential treatment of pancreatic ductal adenocarcinoma.

2024-9-3

Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study

2024-9-2

From diagnosis to survivorship addressing the sexuality of women during cancer

2024-9-1

Correction to: Entinostat in patients with relapsed or refractory abdominal neuroendocrine tumors

2024-8-31

Telemedicine-based serious illness conversations, healthcare utilization, and end of life care among patients with advanced lung cancer

2024-8-29

Breadth versus depth: whole transcriptome sequencing has reduced sensitivity for detection of clinically relevant fusions compared to RNA comprehensive genomic profiling

2024-8-28

Genomic landscape of malignant phyllodes tumors reveals multiple targetable opportunities

2024-8-27

Immune checkpoint inhibitor infusion times and clinical outcomes in patients with melanoma

2024-8-27

Relacorilant plus nab-paclitaxel for the treatment of metastatic pancreatic ductal adenocarcinoma: results from the open-label RELIANT study

2024-8-26

BRCA1/2 mutations and outcomes among Middle Eastern patients with early-onset breast cancer in Oman

2024-8-26

Liquid biopsy in renal cell carcinoma

2024-8-26

Arm symptom pattern among breast cancer survivors with and without lymphedema: a contemporaneous network analysis

2024-8-24

Systemic inflammation and changes in physical well-being in patients with breast cancer: a longitudinal study in community oncology settings

2024-8-23

Recruitment of informal caregivers into community oncology research studies: results from the 2022 Landscape Assessment

2024-8-22

Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US

2024-8-21

Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma

2024-8-21

Espying sarcopenia in gastric cancer: squaring the circle

2024-8-20

Predominance of hyperprogression in mucosal melanoma during anti-PD-1 monotherapy treatment

2024-8-20

Correction to: Prediction of moderate and severe toxicities of chemotherapy in older patients with cancer: a propensity weighted analysis of ELCAPA cohort

2024-8-19

Correction to: Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma

2024-8-19

Treatment of Acute Myeloid Leukemia in the Community Setting

2024-8-19

Association of human papillomavirus genotype and phylogenic clade with oropharyngeal cancer outcomes

2024-8-13

Assessment of psycho-oncology in the Middle East and North Africa region: a systematic review and meta-analysis

2024-8-13

Correction to: Enhanced stiffness in peri-cancerous tissue: a marker of poor prognosis in papillary thyroid carcinoma with lymph node metastasis

2024-8-13

Correction to: Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis

2024-8-13

Unique brain injury patterns after proton vs photon radiotherapy for WHO grade 2-3 gliomas

2024-8-10

Social supports in patients with cancer attending an Irish cancer center: a cross-sectional study

2024-8-9

Closing the gap: prognostic and predictive biomarker validation for personalized care in a Latin American hormone-dependent breast cancer cohort

2024-8-8

Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma

2024-8-7

69 Adherence to the ASCO Language of Respect guidelines in renal cell carcinoma abstracts in an international oncology meeting

2024-8-5

59 Risk Factors of Immune Related Adverse Events in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors

2024-8-5

71 Exploring DNA-methylation and DNA-hydroxymethylation in clear cell renal cell carcinoma using Dirichlet multinomial regression

2024-8-5

74 Unraveling the Complexities of Obesity in Clear Cell Renal Cell Carcinoma Carcinogenesis

2024-8-5

26 Applying single cell RNA sequencing of sarcomatoid renal cell carcinoma for the development of a novel transcriptomic biomarker to predict immunotherapy response

2024-8-5

39 Safety profile of belzutifan monotherapy in patients with renal cell carcinoma: A pooled analysis of 4 clinical trials

2024-8-5

6 Durable response to immunotherapy-based regimens for IMDC favorable risk patients with metastatic clear cell renal cell carcinoma: a pooled analysis of four published randomized control phase 3 trials

2024-8-5

51 Epigenetic regulation of ribosomal RNA transcription and processing by the tumor suppressor SETD2

2024-8-5

25 Enrichment of tertiary lymphoid structures provides novel insight into mediators of anti-tumor immune activity in sarcomatoid renal cell carcinoma

2024-8-5

75 WIRE: Window of Opportunity Clinical Trials Platform for Evaluation of Novel Treatments Strategies in Renal Cell Cancer

2024-8-5

42 Belzutifan versus everolimus for previously treated advanced clear cell renal cell carcinoma: Subgroup analysis of the phase 3 LITESPARK-005 study

2024-8-5

16 Linking VHL and SETD2 in a common oncogenic pathway that converges on the mitoticspindle

2024-8-5

22 Association of a germline single nucleotide polymorphism (SNP) in the interleukin-7 (IL7) gene with immune-related adverse events (irAEs)

2024-8-5